Insightec is a global medical technology company pioneering non-invasive focused ultrasound (FUS) treatments. The company developed the Exablate Neuro platform — the first and only FDA-approved MRI-guided focused ultrasound system for treating tremor in patients with [Parkinson's disease](/diseases/parkinsons-disease) and [essential tremor](/diseases/essential-tremor)[@insightec2024].
Insightec's technology enables clinicians to perform non-invasive thalamotomy — ablating the Vim (ventral intermediate) nucleus of the thalamus — without surgical incision, radiation, or implantation. This represents a paradigm shift from traditional surgical approaches like [deep brain stimulation (DBS)](/companies/boston-scientific) which require hardware implantation["@exablate"].
Company Overview
| Attribute | Details | |-----------|---------| | Headquarters | Haifa, Israel | | Founded | 1999 | | CEO | Maurice R. Ferré (CEO & Chairman) | | Employees | 500+ | | Key Product | Exablate Neuro | | Regulatory Status | FDA approved for ET and PD tremor |
Technology Platform
Exablate Neuro
The Exablate Neuro system consists of:
Phased Array Transducer: 1,024 ultrasound elements arranged in a hemispherical configuration
MRI Guidance: Real-time thermometry and anatomical visualization
Treatment Planning Software: Automated trajectory and energy calculation
Patient Interface: Stereotactic frame with integrated transducer
Mechanism of Action
The system delivers concentrated ultrasound energy to a precise focal point in the brain:
Thermal Ablation: Temperature reaches 54-60°C causing immediate coagulative necrosis
MRI Thermometry: Real-time temperature mapping ensures precise lesion creation
No Incision: Transcranial delivery through intact skull eliminates surgical risks
The procedure is performed under conscious sedation, with patients typically going home the same day[@nejm2016].
Clinical Applications
Parkinson's Disease Tremor
Insightec's primary indication in PD is tremor-dominant Parkinson's disease with the following characteristics:
[FDA Approval for Essential Tremor](https://www.fda.gov/news-events/press-announcements/fda-approves-first-focused-ultrasound-device-treat-essential-tremor)
[Elias et al., NEJM 2016](https://doi.org/10.1056/NEJMoa1600159)
[FDA Approval for Parkinson's Disease](https://www.fda.gov/medical-devices/medical-device-news/fda-approves-mri-guided-focused-ultrasound-treat-tremor-dominant-parkinsons-disease)